Prospective and retrospective primary prevention of Hemoglobinopathies in multiethnic societies

Clinical Biochemistry

Volumn 42, Issue 18, 2009, Pages 1757-1766

  Giordano, Piero C ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Immigration; Prevention; Sickle Cell Disease; Thalassemia

Indexed keywords

ENDEMIC DISEASE; ETHNICITY; FIRST TRIMESTER PREGNANCY; GENETIC COUNSELING; GENETIC SCREENING; HEMOGLOBINOPATHY; HETEROZYGOTE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIGH RISK POPULATION; HUMAN; IMMIGRATION; LABORATORY DIAGNOSIS; LEGAL ABORTION; MEDICAL ETHICS; NEWBORN SCREENING; PRENATAL SCREENING; PRIORITY JOURNAL; REVIEW; UNITED STATES;

ABORTION, INDUCED; ETHNIC GROUPS; EUROPE; FEMALE; GENETIC COUNSELING; GENETIC TESTING; HEMOGLOBINOPATHIES; HETEROZYGOTE; HUMANS; INFANT, NEWBORN; LABORATORY TECHNIQUES AND PROCEDURES; NEONATAL SCREENING; PREGNANCY; PREMARITAL EXAMINATIONS; REPRODUCIBILITY OF RESULTS;

EID: 70450224681     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2009.06.027     Document Type: Review

References (62)

1. Silvestroni E., and Bianco I. Screening for microcytemia in Italy: analysis of data collected in the past 30 years. Am. J. Hum. Genet. 27 2 (1975 Mar) 198-212
2. Fessas P. Prevention of thalassaemia and haemoglobin S syndromes in Greece. Acta. Haematol. 78 2-3 (1987) 168-172
3. Angastiniotis M., Kyriakidou S., and Hadjiminas M. The Cyprus thalassemia control program. Birth Defects Orig. Artic. Ser. 23 5B (1988) 417-432
4. Cürük M.A., Zeren F., Genç A., Ozavci-Aygün S., Kilinç Y., and Aksoy K. Prenatal diagnosis of sickle cell anemia and beta-thalassemia in southern Turkey. Hemoglobin 32 6 (2008) 525-530
5. Lee A.C., Ha S.Y., Wong K.W., et al. So KT. Prevention of beta-thalassemia major by antenatal screening in Hong Kong. Pediatr. Hematol. Oncol. 15 3 (1998 May-Jun) 249-254
6. Fucharoen S., and Winichagoon P. Thalassemia in South East Asia: problems and strategy for prevention and control. Southeast Asian J. Trop. Med. Public Health 23 4 (1992 Dec) 647-655
7. Elgawhary S., Elbaradie Sahar M.Y., Rashad W.M., et al. Prenatal diagnosis of beta-thalassemia in Egypt: implementing accurate high-tech methods did not reflect much on the outcome. Pediatr. Hematol. Oncol. 25 6 (2008 Sep) 541-548
8. Moronkola O.A., and Fadairo R.A. University students in Nigeria: knowledge, attitude toward sickle cell disease, and genetic counseling before marriage. Int. Q. Community Health Educ. 26 1 (2006-2007) 85-93
9. Hoppe C. Newborn screening for Hemoglobinopathies in the U.S. Journal compilation, Special Issue, International Journal of Laboratory Hematology 31 Suppl. 1 (2009) 27-28
10. Schulpen T.W., van der Lee J.H., van der Most van Spijk M.W., and Beemer F.A. Genetic carrier screening for hemoglobinopathies in the Netherlands is not opportune. Ned. Tijdschr. Geneeskd. 142 18 (1998) 1019-1022
11. Cao A., Furbetta M., Galanello R., et al. Prevention of homozygous beta-thalassemia by carrier screening and prenatal diagnosis in Sardinia. Am. J. Hum. Genet. 33 4 (1981 Jul) 592-605
12. Angastiniotis M.A., and Hadjiminas M.G. Prevention of thalassaemia in Cyprus. Lancet. 1 8216 (1981 Feb. 14) 369-371
13. Calefato J.M., Nippert I., Harris H.J., et al. Assessing educational priorities in genetics for general practitioners and specialists in five countries: factor structure of the Genetic-Educational Priorities (Gen-EP) scale. Genet. Med. 10 2 (2008 Feb) 99-106
14. La Pean A., and Farrell M.H. Initially misleading communication of carrier results after newborn genetic screening. Pediatrics 116 6 (2005 Dec) 1499-1505
15. Orsini A., Vovan L., Lena-Russo D., et al. School screening of hemoglobinopathies in the Marseilles area. An analytic study of 35,289 tests. Arch. Fr. Pediatr. 44 6 (1987 Jun-Jul) 455-459
16. Lena-Russo D., Badens C., Aubinaud M., et al. Outcome of a school screening programme for carriers of haemoglobin disease. J. Med. Screen. 9 2 (2002) 67-69
17. Amato A, Grisanti P, Lerone M, et al. The need for new prevention strategies for severe hemoglobinopathies in endemic and non endemic immigration countries: the Italian Latium example. (Submitted for publication).
18. Bozkurt G. Results from the north Cyprus thalassemia prevention program. Hemoglobin 31 2 (2007) 257-264
19. Najmabadi H., Ghamari A., Sahebjam F., et al. Fourteen-year experience of prenatal diagnosis of thalassemia in Iran. Community Genet. 9 2 (2006) 93-97
20. Samavat A., and Modell B. Iranian national thalassaemia screening programme. BMJ 329 7475 (2004 Nov 13) 1134-1137
21. Nikuei P., Hadavi V., Rajaei M., Saberi M., Hajizade F., and Najmabadi H. Prenatal diagnosis for beta-thalassemia major in the Iranian province of Hormozgan. Hemoglobin 32 6 (2008) 539-545
22. Cao A. Carrier screening and genetic counselling in beta-thalassemia. Int. J. Hematol. 76 Suppl 2 (2002 Aug) 105-113 Review
23. Kanavakis E., Traeger-Synodinos J., Vrettou C., Maragoudaki E., Tzetis M., and Kattamis C. Prenatal diagnosis of the thalassaemia syndromes by rapid DNA analytical methods. Mol. Hum. Reprod. 3 6 (1997 Jun) 523-528
24. Thomas P., Oni L., Alli M., et al. Antenatal screening for haemoglobinopathies in primary care: a whole system participatory action research project. Br. J. Gen. Pract. 55 515 (2005 Jun) 424-428
25. Giordano P.C., Plancke A., Van Meir C.A., et al. Carrier diagnostics and prevention of hemoglobinopathies in early pregnancy in The Netherlands: a pilot study. Prenat. Diagn. 26 8 (2006 Aug) 719-724
26. Basran R.K., Patterson M., Walker L., et al. Prenatal diagnosis of hemoglobinopathies in Ontario, Canada. Ann. N. Y. Acad. Sci. 1054 (2005) 507-510
27. Streetly A., Latinovic R., Hall K., and Henthorn J. Implementation of universal newborn bloodspot screening for sickle cell disease and other clinically significant haemoglobinopathies in England: screening results for 2005-7. J. Clin. Pathol. 62 1 (2009 Jan) 26-30
28. Giordano P.C. Starting neonatal screening for haemoglobinopathies in The Netherlands. J. Clin. Pathol. 62 1 (2009 Jan) 18-21
29. Bardakdjian-Michau J., Bahuau M., Hurtrel D., et al. Neonatal screening for sickle cell disease in France. J. Clin. Pathol. 62 1 (2009 Jan) 31-33
30. Mantikou E, Arkesteijn SG, Beckhoven van J, Kerkhoffs J-L, Harteveld CL, Giordano PC. Advances in newborn screening of the hemoglobinopathies: selection of putative beta thalassemia carriers by gestational age related estimation of the HbA fraction. (Submitted for publication).
31. Shine J.W. Microcytic anemia. Am. Fam. Physician. 55 7 (1997 May 15) 2455-2462
32. [No athors listed] a.u.t.h.o.r.s. Intraoperative death during caesarian section in a patient with sickle-cell trait. The Anaesthesia Advisory Committee to the Chief Coroner of Ontario. Can. J. Anaesth. 34 1 (1987 Jan) 67-70
33. Robitaille N., Delvin E.E., and Hume H.A. Newborn screening for sickle cell disease. A 1988-2003 Quebec experience Paediatr. Child Health 11 4 (2006 Apr) 223-227
34. Kolnaar B.G., Pijnenborg L., van Wijk M.A., and Assendelft W.J. The practice guideline 'Anemia' from the Dutch College of General Practitioners. Ned. Tijdschr. Geneeskd. 147 44 (2003 Nov 1) 2193-2194
35. Lippincott Williams & Wilkins Professional Guide to Diseases Hardbound, 8th Edition Springhouse editor ISBN: 1-58255-370-X.
36. Modell B., Darlison M., Birgens H., et al. Epidemiology of haemoglobin disorders in Europe: an overview. Scand. J. Clin. Lab. Invest. 67 1 (2007) 39-69 Review
37. Giordano P.C., and Harteveld C.L. Prevention of hereditary haemoglobinopathies in The Netherlands. Ned. Tijdschr. Geneeskd. 150 39 (2006 Sep. 30) 2137-2141
38. Al-Gazali L., Hamamy H., and Al-Arrayad S. Genetic disorders in the Arab world. Br. Med. J. 333 (2006) 831-834
39. Van Delft P, Lenters E, Bakker-Verweij M, et al. Evaluating five dedicated automatic devices for hemoglobinopathy diagnostics in multi ethnic populations. IJLH (ahead of print April 2009).
40. Giordano P.C., Smit J.W., Herruer M., et al. Dragerschapdiagnostiek en preventie van sikkelcelziekte en thalassemia major; aanbevelingen van de werkgroep Hemoglobinopathieën. Ned. Tijdschr. Klin. Chem. Labgeneesk. 31 (2006) 301-305
41. Hoppe C., Azimi M., Aslanian S., Lubin B.H., Vichinsky E.P., and Therrell B. An effective program to resolve ambiguous results from state newborn hemoglobinopathy screening. Blood 3563a (2004) 104
42. Wild B.J., and Green BN Stephens A.D. The potential of electrospray ionization mass spectrometry for the diagnosis of hemoglobin variants found in newborn screening. Blood Cells Mol. Diseases 33 (2004) 308-317
43. Cowan R.S. Moving up the slippery slope: mandated genetic screening on Cyprus. Am. J. Med. Genet. C. Semin. Med. Genet. 151C 1 (2009 Feb 15) 95-103
44. Chadwick R., ten Have H., Husted J., et al. Genetic screening and ethics: European perspectives. J. Med. Philos. 23 3 (1998 Jun) 255-273
45. Karetti M., Yardumian A., Karetti D., and Modell B. Informing carriers of beta-thalassemia: giving the good news. Genet. Test 8 2 (2004 Summer) 109-113
46. Tunçbilek E., and Özgüç M. Application of medical genetics in Turkey. Turk. J. Pediatr. 49 (2007) 353-359
47. Naamane-Guessous S. Traditional methods still widely used. Plan. Parent. Chall. 1 (1993) 14-16
48. Giordano P.C., Dihal A.A., and Harteveld C.L. Estimating the attitude of immigrants toward primary prevention of the hemoglobinopathies. Prenat. Diagn. 25 (2005) 885-893
49. Giordano P.C., Harteveld C.L., and Bernini L.F. The need for diagnosis and prevention of hemoglobinopathies in Northern Europe: the Dutch situation. Haematologica 84 (1999) 103-104
50. Giordano P.C., and Harteveld C.L. Hemoglobinopathies in The Netherlands: the role of the GP in carrier diagnostics and prevention (in Dutch). Huisarts. Wet. 6 (1998) 290-295
51. Elion-Gerritzen W.E., Giordano P.C., and Haak H.L. Anemia in the midwife practice. Standard issued by the Royal Dutch Organisation of Midwives: a risk of not recognizing iron deficiency and hemoglobinopathy. Ned. Tijdschr. Geneeskd. 146 10 (2002) 457-459
52. Giordano P.C., Harteveld C.L., Dihal A., and Bernini L.F. Prevention of hemoglobinopathies in the Netherlands: an individual approach based on information and prospective diagnostiscs. Hematol. J. 1 31 (2000) P120
53. Giordano P.C., and Harteveld C.L. Information and carrier diagnostiscs as a basis for hemoglobinopathies prevention in The Netherlands: a task for the first line healthcare. Eur. Jour. Hum. Genet. 8 1 (2000) 54 P128
54. Giordano PC, Harteveld CL, Bernini LF. Prevention of hemoglobinopathies in the immigrant populations of northern Europe: The Netherlands. The 8th International Conference on Thalassemia and the Hemoglobinopathies 2001; abstract nr P09.
55. Giordano P.C. Toward state of the art neonatal screening for secondary and primary prevention of the Hemoglobinopathies in The Netherlands. Report Zon-MW isbn 90-807039-2-3.
56. Bouva M., Elvers B., Giordano P.C., and Loeber G. Pilot newborn screening for hemoglobinopathies in the Netherlands using the Variant NBS. The 6th meeting of the International Society for Neonatal Screening (2006), Awaji, Japan, ISNS
57. Verheul F.E.A.M., Brinkman H.B.J.M., and Mohrmann K. Pilot project neonatal screening for hemoglobinopathies using 3 different HPLC systems. The 6th meeting of the International Society for Neonatal Screening (2006), Awaji, Japan, ISNS
58. Peters M., Appel I.M., Cnossen M.H., Breuning-Boers J.M., and Heijboer H. Opgespoorde Kinderen in het eerste jaar. Ned. Tijdschr. Geneeskd. 153 (2009) B359
59. Vansenne F., de Borgie C.A.J.M., Bouva M.J., et al. Sikkelcelziekte in de hielprikscreening II. Gerapporteerd dragerschap. Ned. Tijdschr. Geneeskd. 153 (2009) B366
60. Lakeman P., Plass A.M., Henneman L., Bezemer P.D., Cornel M.C., and ten Kate L.P. Three-month follow-up of Western and non-Western participants in a study on preconceptional ancestry-based carrier couple screening for cystic fibrosis and hemoglobinopathies in the Netherlands. Genet. Med. 10 11 (2008 Nov) 820-830
61. Wijk van M.A.M., Mel M., Muller P.A., Silverentand W.G.J., Pijnenborg L., and Kolnaar B.G.M. NHG Standaard Anemie. Huisarts. Wet. 46 (2003) 3-11
62. Rutten G.E.H.M., De Grauw W.J.C., Nijpels G., et al. NHG-Standaard Diabetes mellitus type 2. Huisarts. Wet. 49 3 (2006) 137-152